These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 24551032)
1. Simultaneous inhibition of the HGF/MET and Erk1/2 pathways affect uveal melanoma cell growth and migration. Chattopadhyay C; Grimm EA; Woodman SE PLoS One; 2014; 9(2):e83957. PubMed ID: 24551032 [TBL] [Abstract][Full Text] [Related]
2. Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner. Khalili JS; Yu X; Wang J; Hayes BC; Davies MA; Lizee G; Esmaeli B; Woodman SE Clin Cancer Res; 2012 Aug; 18(16):4345-55. PubMed ID: 22733540 [TBL] [Abstract][Full Text] [Related]
3. Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma. Cheng H; Chua V; Liao C; Purwin TJ; Terai M; Kageyama K; Davies MA; Sato T; Aplin AE Mol Cancer Ther; 2017 Mar; 16(3):516-528. PubMed ID: 28138035 [TBL] [Abstract][Full Text] [Related]
4. The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma. Wu X; Zhu M; Fletcher JA; Giobbie-Hurder A; Hodi FS PLoS One; 2012; 7(1):e29622. PubMed ID: 22253748 [TBL] [Abstract][Full Text] [Related]
5. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells. Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991 [TBL] [Abstract][Full Text] [Related]
6. Protein kinase C inhibitors sensitize GNAQ mutant uveal melanoma cells to ionizing radiation. Cerne JZ; Hartig SM; Hamilton MP; Chew SA; Mitsiades N; Poulaki V; McGuire SE Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2130-9. PubMed ID: 24595385 [TBL] [Abstract][Full Text] [Related]
7. Active notch protects MAPK activated melanoma cell lines from MEK inhibitor cobimetinib. Porcelli L; Mazzotta A; Garofoli M; Di Fonte R; Guida G; Guida M; Tommasi S; Azzariti A Biomed Pharmacother; 2021 Jan; 133():111006. PubMed ID: 33202284 [TBL] [Abstract][Full Text] [Related]
8. Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma. Papa E; Weller M; Weiss T; Ventura E; Burghardt I; Szabó E Cell Death Dis; 2017 Dec; 8(12):3210. PubMed ID: 29238047 [TBL] [Abstract][Full Text] [Related]
9. Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype. Ho AL; Musi E; Ambrosini G; Nair JS; Deraje Vasudeva S; de Stanchina E; Schwartz GK PLoS One; 2012; 7(7):e40439. PubMed ID: 22808163 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of mutant GNAQ signaling in uveal melanoma induces AMPK-dependent autophagic cell death. Ambrosini G; Musi E; Ho AL; de Stanchina E; Schwartz GK Mol Cancer Ther; 2013 May; 12(5):768-76. PubMed ID: 23443802 [TBL] [Abstract][Full Text] [Related]
11. ERK2 but not ERK1 mediates HGF-induced motility in non-small cell lung carcinoma cell lines. Radtke S; Milanovic M; Rossé C; De Rycker M; Lachmann S; Hibbert A; Kermorgant S; Parker PJ J Cell Sci; 2013 Jun; 126(Pt 11):2381-91. PubMed ID: 23549785 [TBL] [Abstract][Full Text] [Related]
12. Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance. Ambrosini G; Pratilas CA; Qin LX; Tadi M; Surriga O; Carvajal RD; Schwartz GK Clin Cancer Res; 2012 Jul; 18(13):3552-61. PubMed ID: 22550165 [TBL] [Abstract][Full Text] [Related]
13. MET oncogene inhibition as a potential target of therapy for uveal melanomas. Abdel-Rahman MH; Boru G; Massengill J; Salem MM; Davidorf FH Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3333-9. PubMed ID: 20164465 [TBL] [Abstract][Full Text] [Related]
14. Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations. Boru G; Cebulla CM; Sample KM; Massengill JB; Davidorf FH; Abdel-Rahman MH Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2474-2480. PubMed ID: 31173078 [TBL] [Abstract][Full Text] [Related]
15. Higher cMET dependence of sacral compared to clival chordoma cells: contributing to a better understanding of cMET in chordoma. Lohberger B; Scheipl S; Heitzer E; Quehenberger F; de Jong D; Szuhai K; Liegl-Atzwanger B; Rinner B Sci Rep; 2021 Jun; 11(1):12466. PubMed ID: 34127734 [TBL] [Abstract][Full Text] [Related]
16. Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations. Chen X; Wu Q; Tan L; Porter D; Jager MJ; Emery C; Bastian BC Oncogene; 2014 Sep; 33(39):4724-34. PubMed ID: 24141786 [TBL] [Abstract][Full Text] [Related]
17. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells. Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235 [TBL] [Abstract][Full Text] [Related]
18. Genotype-dependent sensitivity of uveal melanoma cell lines to inhibition of B-Raf, MEK, and Akt kinases: rationale for personalized therapy. Mitsiades N; Chew SA; He B; Riechardt AI; Karadedou T; Kotoula V; Poulaki V Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7248-55. PubMed ID: 21828154 [TBL] [Abstract][Full Text] [Related]
19. Identification of common predictive markers of in vitro response to the Mek inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell lines. Garon EB; Finn RS; Hosmer W; Dering J; Ginther C; Adhami S; Kamranpour N; Pitts S; Desai A; Elashoff D; French T; Smith P; Slamon DJ Mol Cancer Ther; 2010 Jul; 9(7):1985-94. PubMed ID: 20587667 [TBL] [Abstract][Full Text] [Related]
20. c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential. Wu X; Zhou J; Rogers AM; Jänne PA; Benedettini E; Loda M; Hodi FS Melanoma Res; 2012 Apr; 22(2):123-32. PubMed ID: 22343486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]